Company intelligence / Profile preview
Cannabis Bioscience International Holdings, Inc.
Houston, Texas, United Statescbih.net ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
CBIH has filed at least six utility non-provisional patents for cannabinoid-based therapies targeting major unmet medical needs including breast and pancreatic cancers. The company’s strategy centers on building robust IP and preparing for the declassification of cannabis to enable more clinical research. No published human trial results yet; focus remains on preclinical development and establishing itself as a leading cannabis-focused CRO.[7][9]
- Therapeutic areas
- OncologyInfectious DiseasesRheumatologyNeurologyWomen's Health
- Modalities
- Cannabinoid-based therapeutics[9]
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Beyond the preview
Go deeper on Cannabis Bioscience International Holdings, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cannabis Bioscience International Holdings, Inc..